Summary: Some patients undergoing epilepsy surgery suffer from early postoperative seizures which may have a negative impact on later outcome. Factors contributing to these seizures have not to date been examined systematically. We hypothesized that reduction of postoperative serum levels of antiepileptic drugs (AED) may be one risk factor for early postoperative seizures. Methods: We retrospectively reviewed medical records from 20 patients treated with lamotrigine (LTG) who underwent epilepsy surgery between January 1997 and February 2004. Demographic data, anaesthesiological and surgical procedures, co-medication, and pre-as well as one or more postoperative LTG serum levels were evaluated. Results: We found a significant decrease in LTG serum levels, amounting to more than 20% (mean 46%, range 21.9-69.1%), in 16 of 20 patients (80%). Six patients (30%) suffered from seizures in the first 2 weeks after surgery. In three patients, postoperative seizures occurred isochronically with the LTG serum level nadir. The magnitude of the reduction in serum levels was not influenced by age, sex, duration of the operation, the type of anaesthetic drugs or the postoperative co-medication. Discussion: Reductions in LTG serum levels are a relevant contributing factor for early postoperative seizures. Postoperative alteration of the gastrointestinal motility and
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Introduction
Epilepsy surgery is an established therapeutic alternative for a subgroup of patients with medically intractable focal epilepsies. 1 Although as many as 49% of patients may develop seizures in the early postoperative period and these seizures may predict subsequent seizure recurrence, 2-4 our knowledge of the precipitating conditions of seizures in the first few postoperative days is sparse. One of these conditions might be fluctuations in the serum levels of the antiepileptic drugs (AED) usually continued after surgery for a duration of at least 2 years. Few retrospective studies have previously assessed changes in postoperative serum levels of carbamazepine (CBZ), lamotrigine (LTG) or oxcarbazepine (OXC). [5] [6] [7] [8] Our observation of early postoperative seizures associated with a pronounced decrease in LTG serum levels a few days after surgery in two of our patients prompted us to perform a systematic retrospective review of medical records as well as surgery and anaesthesia protocols from patients operated on in our clinic under medication with LTG.
Patients and methods

Patients and procedures
Out of a total number of 272 surgically treated epilepsy patients (anterior temporal lobectomy/ amygdalohippocampectomy, implantation of subdural grid electrodes) between January 1997 and February 2004, we identified 20 patients (12 female, 8 male, mean age 34 years (range 13-56)), who were on stable medication with LTG at least 1 month prior to surgery and from whom at least one serum level from the last or second last day before surgery and from 1 postoperative day (POD) during the first 2 weeks after surgery was available. The number of available postoperative LTG serum levels and the duration of the follow-up period ranged from 1 to 6 and from POD 1/2 to POD 13, respectively (Fig. 1) . All serum samples were drawn during drug fasting in the morning. Mean preoperative LTG dose was 551 mg/ day (200-800, S.D. 136.7). Twelve patients had an LTG monotherapy, 8 patients received co-medication with other AED (2 CBZ (1000 mg, 1800 mg), 3 levetiracetam (LEV) (2000 mg, 3000 mg, 3500 mg), 1 valproic acid (VPA) (2000 mg), 1 OXC (2700 mg) and 1 primidone (PRM) (625 mg)).
All patients received total intravenous anaesthesia (TIVA) with propofol and remifentanil; three patients received additional inhalation anaesthesia with isoflurane. In all patients rocuronium or cisatracurium was used for muscle relaxation, and 40 mg dexamethasone, 2 g ceftriaxone or 3 g ampicillin/sulbactam and 1 or 2 g metamizole were administered at the end of the operation. Mean duration of the operations was 275 min (120-390, S.D. 67.4). As the intra-and postoperative blood loss could not be quantified precisely in the majority of cases, we decided to exclude this variable. Postoperative drug regimes varied remarkably: 17 out of 20 patients received oral dexamethasone starting with 24 mg daily (3 Â 8 mg) on POD 1 and a daily dose reduction of 4-6 mg; 3 patients did not receive steroids. In 12 cases the H2-antihistamine ranitidine was given for postoperative ulcer prophylaxis, 3 patients had proton pump inhibitors (omeprazole, esomeprazole) and 5 patients had no ulcer prophylaxis. Seven out of 20 patients received paracetamol (acetaminophen) for postoperative analgesia; 13 patients received other oral analgetics (metamizole, ibuprofen).
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F. Paul et al. Besides testing for AED serum levels, routine postoperative monitoring of the patients until discharge from the ward (usually 10-14 days after surgery) included the following procedures: drawing of blood samples (white blood cell count, haemoglobin, platelet count, Na, K, CRP, glucose, liver enzymes) at least every other day, daily measurement of body temperature, measurement of blood pressure and pulse three times daily, urine analysis at least once during the first few postoperative days, and a neurological examination at least every other day. If necessary, further diagnostic examinations (computed tomography of the brain, ECG, etc.) were performed.
Statistics
Established parameters of descriptive statistics (mean, range, standard deviation) were calculated. A Wilcoxon rank-sum test was used for pre-and postoperative comparisons, and a Mann-Whitney test for between group comparisons. A p-value <0.05 was considered significant. All procedures were performed with SPSS version 12.0.
Results
In the entire group, mean decrease of LTG serum levels from the preoperative baseline was 37% (mean preoperative level 8.1 mg/l (3.4-16.2, S.D. 3.6), lowest mean postoperative level 5.1 mg/l (1.4-9.9, S.D. 2.6; p = 0.001). Sixteen out of 20 patients (80%) showed a decrease in LTG serum levels from baseline of more than 20% (21.9-69.1%, mean 46%) ( p < 0.001, Table 1 , Fig. 1 ), 2 patients had increased serum levels (+41.1%, +35.9%) and 2 patients showed minor changes (À7.7%, +15.3%). Decrease of LTG serum levels did not differ significantly between men and women, patients with or without paracetamol, with or without isoflurane anaesthesia, with different medication for ulcer prophylaxis or with or without dexamethasone. Furthermore, the magnitude of the decrease was influenced neither by age nor by the preoperative serum level.
Six patients (four with LTG monotherapy, two with LEV co-medication) suffered from one or more seizures within the early postoperative period (POD 1 to POD 13); two additional patients presumably had one seizure each, but documentation was insufficient. Five out of the six patients showed a reduction in LTG levels of between 22.2% and 66.3% (mean 48.4%) from the preoperative baseline, one patient had a non-significant increase of 15.3%. There was, however, no significant difference in decrease of serum levels between the group of patients with documented postoperative seizures (n = 6) and the group of patients without postoperative seizures (n = 14). In four patients with postoperative seizures, serum levels from the day on which the seizures occurred were documented in the medical records. In three of these patients seizures correlated with the nadir of the serum levels (pat. 9: POD 5, decrease of 52.7%; pat. 11: POD 4, decrease of 66.3%; pat. 14: POD 4, decrease of 22.2%; see Fig. 1 , red circles). The fourth patient (pat. 12, LTG monotherapy) had one seizure on POD 3; the serum level on this day was 8.2 mg/l versus 9.9 mg/l preoperatively. This patient's LTG level further decreased to 5.8 mg/l, which led to the administration of 30 mg clobazam. The remaining two patients with postoperative seizures had serum levels drawn 1 day Table 1 Mean pre-and postoperative serum levels (range) of LTG in 16 patients with a decrease of more than 20% from preoperative baseline prior to or not more than 1 day after the seizure. Patient 2 (LTG monotherapy) had blood samples drawn 2 days prior to and 1 day after the seizure; at both timepoints, serum levels were reduced (preoperative: 7.4 mg/l, POD 1: 3.0 mg/l (À59.5%), POD 4: 5.1 mg/l (À31.1%)). Patient 19 (co-medication with LEV) had a seizure on POD 1, the LTG serum level on POD 2 was 6.8 mg/l compared to a preoperative value of 5.9 mg/l. In all six patients suffering from postoperative seizures a dose augmentation of LTG (between 50 mg and 200 mg daily, increase of between 10% and 25% compared to the preoperative dose) was performed and/or additional clobazam medication was temporarily administered to prevent further seizures. In none of these 6 patients were the postoperative seizures related to fever, infections, or laboratory abnormalities such as metabolic disturbances or electrolyte imbalance.
In the subgroup of eight patients with anticonvulsant co-medication, serum levels changed as follows: the PRM (1 pat.) and VPA (1 pat.) levels remained unchanged (pre-/postoperative 6.0 mg/l versus 5.2 mg/l and 102 mg/l versus 96 mg/l, respectively), the patient with OXC co-medication showed a decrease of 41.8%, 1 patient with CBZ co-medication had a fair increase (pre-/postoperative 7.3 mg/l versus 10.8 mg/l) and the second CBZ patient had a decrease of 51.6%. LEV serum levels (3 pats.) were not routinely examined as there was no valid assay available at that time in our institution.
Discussion
Our study revealed a pronounced decrease of between 22% and 69% of LTG serum levels in 16 out of 20 patients (80%) compared to the preoperative steady state. Amongst these 16 patients, 5 had postoperative seizures between POD 1 and POD 13. In 3 of these, seizures were associated with the LTG serum level nadir. As the postoperative seizures in these patients could not be explained by fever, infections or laboratory abnormalities, it is very likely that the reduction of LTG serum levels after surgery played a crucial role. Reduction of AED serum levels is a well-known seizure-provoking condition. 9 The factors contributing to the postoperative decrease of serum levels are, however, elusive. Besides the surgical procedure itself, possible influencing factors include the anaesthetic drugs, the perioperative medication (muscle relaxation, antibiotics) and the postoperative medication, which included dexamethasone, H2-antihistamines (ranitidine) or proton pump inhibitors (omeprazole, esomeprazole), and the analgetics paracetamol (acetaminophen), metamizole and ibuprofen. Little is known about drug interactions of these co-medications with LTG or other AED.
Feil et al. 8 examined perioperative serum levels of LTG and OXC, and found relevant fluctuations in patients who received isoflurane and barbiturates as anaesthetics. However, none of our patients received barbiturates, and only three had isoflurane anaesthesia; these patients did not show a more pronounced reduction in LTG levels than the patients without isoflurane. Therefore, isoflurane is unlikely to be the major cause of the decreased serum levels.
Another influencing co-medication may be dexamethasone, which was administered in 17 patients. Sabers et al. found a significant reduction of LTG levels under oral contraceptives 10, 11 and speculated that this might be due to the elimination of LTG primarily by glucuronidation, as oral contraceptives induce the metabolism of some other glucuronidated drugs such as paracetamol and clofibric acid. 12, 13 Dexamethasone is a steroid as well, so similar effects on the pharmacokinetics of LTG may be assumed. Two of 3 patients who did not receive dexamethasone had only minor fluctuations in their LTG levels (À7.7%, +15%), but the small number of patients does not allow firm conclusions to be drawn regarding possible interactions of LTG with dexamethasone.
Drug interactions of H2-antihistamines and proton pump inhibitors with LTG have not been thoroughly investigated. Although sample sizes were limited, the lack of changes dependent on these drugs in our study is in line with Ebert et al., who found negligible effects of the H2-antihistamine cimetidine on the pharmacokinetics of LTG in healthy subjects after administration of a single oral dose of 25 mg LTG. 14 Paracetamol (acetaminophen), given in seven cases for postoperative analgesia, can reduce LTG serum levels. 15 This may be a relevant co-factor in some patients but cannot explain sufficiently the decrease of postoperative LTG serum levels in the entire cohort, as the magnitude of the decrease was similar in patients with and without paracetamol ( Table 1) .
The fact that our study could not show a firm association between the decrease of the serum levels and certain co-medications may be due to the lack of standardised treatment regimes in the early postoperative period, leading to small sample sizes in the different subgroups. On the other hand, this observation may equally point to the anaesthetics (TIVA, given to all patients in our cohort) as a factor influencing postoperative serum level reductions. All types of anaesthesia may cause delayed gastric emptying and alteration of bowel motility, 16 which has also been separately shown for TIVA with propofol and remifentanil in humans. 17 This may lead to a delayed absorption of orally administered medications and an alteration of their bioavailability. 16, 17 The major limitation of our study is, thus, its retrospective character and the relatively small sample size, which hampers the assessment of the impact of the perioperative procedures (surgery, anaesthesia, postoperative medication) on the serum levels of LTG. However, as our knowledge of perioperative fluctuations in AED serum levels is exiguous, this work alerts us to the relevance of decreased AED serum levels as a factor contributing to early postoperative seizures. Early postoperative seizures of whatever cause may have a negative psychological impact on patients, who signed consent for epilepsy surgery with high expectations regarding seizure freedom, mostly after a long history of medically intractable epilepsy. Furthermore, early postoperative seizures may have negative prognostic implications for later outcome. [2] [3] [4] As certain conditions related to surgery, such as anaesthesia, are unavoidable, all susceptible factors which can contribute to postoperative seizures, such as decrease of serum levels of AED, should be eliminated as far as possible. Presumably, a postoperative reduction of serum levels is not a phenomenon specific to LTG: the serum levels of other AED might also be influenced by perioperative procedures, anaesthetics and postoperative medication, a possibility which needs further evaluation. The very small number of patients with anticonvulsants given as co-medication in our study (CBZ, PRM, LEV, VPA, OXC) does not permit any conclusions to be made regarding these AED. Interestingly, elevated postoperative serum levels of CBZ were reported in a previous retrospective study in about 50% of patients undergoing epilepsy surgery, and interaction with fentanyl was assumed. 7 On the other hand, 9% had a reduction of postoperative CBZ levels in the same study.
As an increasing number of patients will probably be eligible for epilepsy surgery owing to improved selection procedures and optimised surgical techniques, prospective studies are urgently needed to assess the factors influencing perioperative fluctuations in AED serum levels and their impact on early postoperative seizures. It would be desirable to reach a consensus amongst experts in the field on a standardized perioperative management of patients undergoing epilepsy surgery regarding anaesthesia, postoperative co-medication presumably interacting with the AED, and dose titration of the AED.
The results of our study lead us to make the following recommendations regarding the perioperative management of epilepsy patients with LTG: (i) a preoperative dose augmentation of 10-20% should be considered in order to avoid insufficient postoperative serum levels and to eliminate one susceptible factor which contributes to postoperative seizures; (ii) a subsequent reduction in dosage to the preoperative steady-state dose could be performed about 2 weeks later after discontinuation of other potentially interacting drugs such as steroids, drugs for ulcer prophylaxis and analgetics; (iii) postoperative serum levels of LTG should be monitored closely (at least every other day) during the first 2 postoperative weeks; (iv) a serum level reduction of more than 20% should initiate further cautious dose augmentation and/or temporary addon medication with benzodiazepines; (v) postoperative analgesia with paracetamol should be handled with caution, as an interaction with LTG cannot be ruled out. Therefore, metamizole or ibuprofen may be preferable alternatives.
